Abstract Body

Interferon-α (IFNα) therapy was associated with significant suppression of HIV viremia and reduction in levels of HIV DNA during suppressive antiretroviral therapy (ART). Cytokines modulate host glycosylation, and glycosylation plays a critical role in mediating several antibody (mainly immunoglobulin G; IgG) immunological functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), and anti-inflammatory activities. Nevertheless, the impact of IFNα on host glycosylation machinery remains unknown.

We assessed the impact of pegylated IFNα2a (Peg-IFNα2a) immunotherapy on isolated IgG glycomes of 18 HIV-mono-infected individuals on suppressive ART, using capillary electrophoresis. We also examined the plasma levels of 1) the immunomodulatory lectins, galectin-1, -3, -9, E-selectin, P-selectin, and L-selectin; and 2) 16 pro- and anti-inflammatory markers and cytokines, using Luminex. ADCC activity was measured using the Chromium-51 (51Cr) release assay. Last, levels of integrated HIV DNA in CD4+ T cells were examined using qPCR. Wilcoxon signed-rank test and Spearman’s correlations were used for statistical analysis. The Bonferroni method was used to correct for multiple comparisons.

Peg-IFNα2a treatment was associated with a significant increase in the proportion of the pro-inflammatory, bisected GlcNAc glycan structures (such as G0FB; Bonferroni-corrected p<0.05). Fold induction of G0FB glycan trait correlated positively with the IFN-α-mediated induction of the pro-inflammatory soluble markers (sCD14 and sCD163; rho>0.56, p<0.016). Peg-IFNα2a also induced the plasma levels of the inflammatory mediators galectin-9 (p=0.0001), L-Selectin (p=0.027), and E-Selectin (p<0.008). IFNα2a-mediated reduction of the anti-ADCC total fucosylated glycans (p<0.05) correlated negatively with fold change in ADCC activity (rho= – 0.52, p=0.026). Last, IFNα-mediated reduction of A2G2S1 glycan trait (p=0.04) correlated positively with change in ADCC activity (rho=0.62, p=0.006), and with IFNα-mediated reduction of integrated HIV DNA levels (rho=0.76, p=0.037).

IFNα immunotherapy in HIV-infected individuals on suppressive ART is associated with glycomic alterations, that are known to mediate higher inflammatory responses and higher innate effector functions. Our data suggest that host glycan-lectin interactions may mediate signals that inform and/or determine host immune responses to HIV persistence during IFN-α treatment.